Lonza primary, diseased primary and stem cells

Wednesday, 14 March, 2012 | Supplied by: Capsugel Australia Pty Ltd

Lonza primary, diseased primary and stem cells

Research shows that non-transformed, non-immortalised cells isolated directly from tissue provide conditions that closely simulate a living model and yield more physiologically significant results.

With Clonetics Primary Normal Cells and Media, Lonza provides over 150 authenticated primary human and animal cell types with optimised media for growth and maintenance.

With Clonetics Primary Diseased Cells, the company offers primary cells derived from patients with COPD, asthma, Type 1 and Type 2 diabetes.

The company’s Stem Cells and Media offer primary human adult stem and progenitor cells from bone marrow, cord blood and adipose tissue with growth and differentiation media, and ES-derived differentiated cells and media.

Lonza primary cells and media are tested together to guarantee performance. The company uses strict industry QC standards to ensure consistent performance on every lot manufactured.

All tissue utilised for the company’s human cell products is ethically obtained with documented and informed donor consent.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

GeneTex carrier-free antibodies

GeneTex's carrier-fee antibodies are BSA-, sodium azide- and glycerol-free, featuring diverse...

Cayman Chemical LipidLaunch Ionizable Lipid LNP Screening Set

The LipidLaunch Ionizable Lipid LNP Screening Set is a screening set of 12 ionisable cationic and...

Antibodies.com neutrophil marker antibodies

Antibodies.com offers a variety of markers that identify neutrophils at various stages of...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd